Navigate Select ESC Close

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

2025-09-29 Entertainment
84.3k
1.4k
65
All-In Podcast
All-In Podcast
1.1m subscribers

Eli Lilly's GLP-1 Success, Capital Allocation, and Biotech Future

Understand how Eli Lilly capitalized on the GLP-1 breakthrough and discover the CEO’s strategy for pricing, R&D reinvestment, and future drug pipeline development.

Short Summary

  • Eli Lilly's GLP-1 drug, Mounjaro, achieved record sales in Q2, highlighting a massive market shift toward metabolic health.
  • Ricks emphasizes aggressive R&D reinvestment (targeting 25% of sales) over pure shareholder payouts to secure the next major breakthrough.
  • The company is countering addiction and mental health crises by developing new GLP-1s specifically targeting brain activity.
  • Lilly is countering supply chain risk and rising Chinese competition by committing to massive, localized US manufacturing expansion.

This interview provides deep insight from CEO Dave Ricks regarding the operational scaling, ethical pricing decisions, and the state of medical innovation financing post-GLP-1 boom. Readers gain context on how a pharma leader manages unprecedented profitability while balancing public health needs and future innovation.

Unlock all features

FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.

Description

(0:00) Introducing Eli Lilly CEO Dave Ricks (1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China (7:08) GLP-1 pricing and capital allocation after a breakout pharma product (12:56) Why Biotech VC has plummeted, “patent hacking” in China (15:32) Dave’s health regimen: good sleep, movement, healthy diet, social relationships, reading (18:32) Unexpected impacts of GLP-1s, helping with addictions, potential mental health use cases (21:16) Thoughts on RFK Jr, Big Pharma’s influence on the media, how AI empowers patients (25:27) Impact of proposed NIH cuts, explaining the “PBM boogeyman”, next major pharma breakthrough Thanks to our partners for making this happen! Solana - Solana is the high performance network powering internet capital markets, payments, and crypto applications. Connect with investors, crypto founders, and entrepreneurs at Solana’s global flagship event during Abu Dhabi Finance Week & F1: https://solana.com/breakpoint OKX - The new way to build your crypto portfolio and use it in daily life. We call it the new money app. https://www.okx.com/ Google Cloud - The next generation of unicorns is building on Google Cloud's industry-leading, fully integrated AI stack: infrastructure, platform, models, agents, and data. https://cloud.google.com/ IREN - IREN AI Cloud, powered by NVIDIA GPUs, provides the scale, performance, and reliability to accelerate your AI journey. https://iren.com/ Oracle - Step into the future of enterprise productivity at Oracle AI Experience Live. https://www.oracle.com/artificial-intelligence/data-ai-events/ Circle - The America-based company behind USDC — a fully-reserved, enterprise-grade stablecoin at the core of the emerging internet financial system. https://www.circle.com/ BVNK - Building stablecoin-powered financial infrastructure that helps businesses send, store, and spend value instantly, anywhere in the world. https://www.bvnk.com/ Polymarket: https://www.polymarket.com/ Athletic Brewing: https://www.athleticbrewing.com/ Follow the besties: https://x.com/chamath https://x.com/Jason https://x.com/DavidSacks https://x.com/friedberg Follow on X: https://x.com/theallinpod Follow on Instagram: https://www.instagram.com/theallinpod Follow on TikTok: https://www.tiktok.com/@theallinpod Follow on LinkedIn: https://www.linkedin.com/company/allinpod Intro Music Credit: https://rb.gy/tppkzl https://x.com/yung_spielburg Intro Video Credit: https://x.com/TheZachEffect Referenced in the show: #allin #tech #news

Top Comments (10)

@ericgeerts7853 2025-09-29

Jason constantly oscillates between being the most cringe bestie and funniest bestie.

131 6 replies
@MS-uu8xg 2025-09-29

30 minutes is not enough for this interview

51 2 replies
@joedirnfeld 2025-09-29

This guy is impressive

46
@randynew7174 2025-09-29

Thank you Dave Ricks. I only took Mounjaro for 4 months. Lost a total of over 60 lbs. and have kept it off without the drug.

33 1 replies
@iHunter808 2025-09-29

Great explanation on the current state of Biotech venture. Investing in these companies post IPO has devolved into binary event gambling to anyone except the 1% who can rationalize the drug’s MOA.

18
@reginaldmaximus 2025-09-29

Great interview

12
@1900Box 2025-09-29

Great interview refreshingly honest and forthcoming. It's like if you had a conversation with this guy you could trust what he would tell you

9
@jaykolath5677 2025-09-30

I just wanna give a S/O to sacks for his insights and contributions to this panel 🙌🏽🙌🏽

4
@bradappel9928 2025-10-13

Great interview held his ground while being ask ten different questions at once, really enjoyed.

0
@t_share8032 2025-10-09

chamath dry humpping his mic on the tie is gold. Why did nobody say or notice... Thank you all for all your hard work!

0

Unlock the Data Inside
Turn Videos into Knowledge

  • Get FREE 10/day: transcripts, summaries, chats
  • Chat with videos, export text & PDF
  • $1 free API credit for RAG, chatbots & research

Free forever plan • All features unlocked

App screenshot